SLC16A1 and prostate carcinoma: Endpoint PCR revealed that DU145 prostate cancer cells (Figure 1A) and HCC1806 triple negative breast cancer cells (Figure 1B) predominantly express MCT1 and MCT4 out of all cancer-associated and proton-linked MCTs analyzed.